Related references
Note: Only part of the references are listed.Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma
Hidetaka Yamamoto et al.
HUMAN PATHOLOGY (2021)
Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion
Bin Xu et al.
HISTOPATHOLOGY (2020)
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls
James P. Solomon et al.
MODERN PATHOLOGY (2020)
Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland
Diana Bell et al.
VIRCHOWS ARCHIV (2020)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a NovelVIM-RETFusion
Alena Skalova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family
Julie Guilmette et al.
HUMAN PATHOLOGY (2019)
Molecular characterization of cancers with NTRK gene fusions
Zoran Gatalica et al.
MODERN PATHOLOGY (2019)
Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma
Yin P. Hung et al.
HISTOPATHOLOGY (2019)
Testing algorithm for identification of patients with TRK fusion cancer
Frederique Penault-Llorca et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C. Marchio et al.
ANNALS OF ONCOLOGY (2019)
Pan-TRK Immunohistochemistry A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast
Beth T. Harrison et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma
Nicolas Piton et al.
LABORATORY INVESTIGATION (2018)
Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases
Alena Skalova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors
Erin R. Rudzinski et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion Expanding the Molecular Spectrum of a Recently Described Entity
Lisa M. Rooper et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics
Yin P. Hung et al.
HISTOPATHOLOGY (2018)
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Theodore W. Laetsch et al.
LANCET ONCOLOGY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon et al.
CANCER DISCOVERY (2017)
Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions
Jaclyn F. Hechtman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia
P. Ruminy et al.
LEUKEMIA (2016)
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
A. Drilon et al.
ANNALS OF ONCOLOGY (2016)
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
Alessio Amatu et al.
ESMO OPEN (2016)
Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity
Alena Skalova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Share Paper
